What AI says about Azafaros

Azafaros is a biotechnology company developing nizubaglustat, an orally available azasugar for treating central nervous system disorders by interfering with glycosphingolipid metabolism. The compound uses a unique dual mode of action to address key disease pathways in rare genetic conditions.